Rapport Therapeutics (RAPP) EBIT (2023 - 2026)
Rapport Therapeutics (RAPP) reported EBIT of -$24.2 million for Q1 2026, up 10.67% year-over-year from -$21.9 million in Q1 2025, and up 37.12% quarter-over-quarter from -$38.5 million in Q4 2025.
Rapport Therapeutics (RAPP) EBIT (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 4 years of EBIT data on file, last reported at -$24.2 million in Q1 2026.
- EBIT for Q1 2026 came in at -$24.2 million, up 10.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$122.2 million (down 31.31% YoY), and the FY2025 annual result was -$125.1 million, down 50.62% from the prior year.
- EBIT improved to -$24.2 million in Q1 2026 per RAPP's latest filing, from -$38.5 million in the prior quarter.
- Over five years, EBIT peaked at -$6.6 million in Q2 2023 and troughed at -$38.5 million in Q4 2025.
- A 4-year average of -$21.9 million and a median of -$22.6 million in 2024 frame the typical range for EBIT.
- The sharpest annual moves came in 2024 and 2026: EBIT slumped 213.73% in 2024, then advanced 10.67% in 2026.
- A 4-year view of EBIT shows it stood at -$14.8 million in 2023, then plunged by 58.99% to -$23.5 million in 2024, then plunged by 63.72% to -$38.5 million in 2025, then surged by 37.12% to -$24.2 million in 2026.
- Business Quant data shows RAPP's EBIT at -$24.2 million in Q1 2026, -$38.5 million in Q4 2025, and -$30.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -65.83 Mn |
| 10 | Rapport Therapeutics | 1.66 Bn | 1.66 Bn | - | -24.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.22 Mn |
| Dec 31, 2025 | -38.51 Mn |
| Sep 30, 2025 | -29.99 Mn |
| Jun 30, 2025 | -29.50 Mn |
| Mar 31, 2025 | -27.11 Mn |
| Dec 31, 2024 | -23.52 Mn |
| Sep 30, 2024 | -21.64 Mn |
| Jun 30, 2024 | -20.80 Mn |
| Mar 31, 2024 | -17.09 Mn |
| Dec 31, 2023 | -14.79 Mn |
| Sep 30, 2023 | -9.56 Mn |
| Jun 30, 2023 | -6.63 Mn |